5 studies were found.

1.		Recruiting	Combination Chemotherapy, Celecoxib, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer Conditions: adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
2.		Recruiting	Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma That Has Relapsed After High-Dose Chemotherapy and Autologous Stem Cell Transplantation Condition: adult non-Hodgkin's lymphoma
3.		Recruiting	Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Conditions: recurrent adult diffuse mixed cell lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult immunoblastic large cell lymphoma
4.		Recruiting	Rituximab and Carmustine, Cytarabine, Etoposide, and Melphalan Followed By Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Condition: adult non-Hodgkin's lymphoma
5.		Recruiting	Vaccine Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma Conditions: recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma